Aleutian Therapeutics is a pre-clinical stage company developing universal stem cells to enable scalable production of a variety of cell therapies. Our proprietary technology aims to restore cellular function in patients by administering engineered cells that evade the immune system. Our approach does not require cell encapsulation, surgical implantation, or toxic immunosuppressive drugs.
While our initial focus is on Type 1 diabetes, our technology has the potential to advance regenerative medicine in a wide variety of applications.
For partnering opportunities or to learn more, contact us at info@aleutiantx.com
Company Details
- Employees
- 4
- Founded
- -
- Address
- San Diego & Los Angeles, California, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- San Diego & Los Angeles, California
Aleutian Therapeutics Questions
Aleutian Therapeutics's LinkedIn profile is https://www.linkedin.com/company/aleutian-therapeutics
Aleutian Therapeutics has
4 employees.
View email and phone details for 4
employees at Aleutian Therapeutics.
Aleutian Therapeutics's industry is
Pharmaceutical Manufacturing
Aleutian Therapeutics's top competitors are
Forcyte Biotechnologies, Inc,
Reneubio Inc,
Symphony Biosciences,
Homelab,
Saber Consulting Llc,
Sparkgene Biotechnology,
Latentspace Therapeutics,
Cytodyme,
Arteri,
The Electric Sunflower Co..
Aleutian Therapeutics's categories are Pharmaceutical Manufacturing
Aleutian Therapeutics's founding year is 2023
